18.95
Schlusskurs vom Vortag:
$17.51
Offen:
$17.53
24-Stunden-Volumen:
396.20K
Relative Volume:
1.21
Marktkapitalisierung:
$335.84M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-6.8659
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
+4.84%
1M Leistung:
-0.16%
6M Leistung:
+61.97%
1J Leistung:
-67.19%
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OM
Outset Medical Inc
|
18.95 | 320.33M | 114.73M | -140.94M | -126.18M | -2.76 |
![]()
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2024-04-08 | Eingeleitet | BTIG Research | Buy |
2024-04-05 | Hochstufung | CL King | Neutral → Buy |
2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
2023-08-17 | Eingeleitet | CL King | Neutral |
2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2021-08-18 | Eingeleitet | Cowen | Outperform |
2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
2020-12-16 | Eingeleitet | Oppenheimer | Perform |
2020-10-12 | Eingeleitet | Barclays | Overweight |
2020-10-12 | Eingeleitet | BofA Securities | Buy |
2020-10-12 | Eingeleitet | Goldman | Buy |
2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical Inc. Stock Analysis and ForecastFree Investment Risk Control - jammulinksnews.com
What drives Outset Medical Inc. stock priceFree Predictions - jammulinksnews.com
Is Outset Medical Inc. a good long term investmentHigh-impact stock picks - Autocar Professional
What analysts say about Outset Medical Inc. stockExplosive market performance - Autocar Professional
Does Outset Medical Inc. stock pay reliable dividendsInstant Stock Updates - newser.com
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - GlobeNewswire
Outset Medical Earnings: Dialysis Tech Pioneer Sets Q2 Results Date, Top Executives to Present - Stock Titan
Institutional investors may adopt severe steps after Outset Medical, Inc.'s (NASDAQ:OM) latest 14% drop adds to a year losses - simplywall.st
Why Outset Medical’s Rock-Bottom Valuation Masks Explosive Growth (NASDAQ:OM) - Seeking Alpha
Top Companies in Smart Dialysis Systems (Jul, 2025) - Tracxn
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Outset Medical, Inc. (OM) Shareholders - ACCESS Newswire
Outset Medical, Inc.(NasdaqGS: OM) added to Russell 3000 Value Index - MarketScreener
Outset Medical Inc (OM) Shares Down 2.93% on Jun 27 - GuruFocus
Renee Gaeta Joins Outset Medical as Chief Financial Officer - Medical Product Outsourcing
FMS Stock Likely to Gain on New Optimization Plan FME Reignite - Yahoo Finance
Outset Medical Inc (OM) Shares Down 5.6% on Jun 17 - GuruFocus
Transcript : Outset Medical, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 11 - marketscreener.com
Outset Medical at Goldman Sachs Conference: Strategic Focus on Acute and Home Dialysis - Investing.com Canada
Outset Medical appoints Renee Gaeta as CFO - MedTech Dive
Outset Medical Inc (OM) Trading 3.49% Higher on Jun 5 - GuruFocus
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Investors Who Suffered Over $300,000 Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference | OM Stock News - GuruFocus
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
BTIG maintains buy rating on Outset Medical stock after CFO change By Investing.com - Investing.com South Africa
Outset Medical Appoints Renee Gaeta as Chief Financial Officer | - GuruFocus
TD Cowen Adjusts Price Target on Outset Medical to $25 From $15, Maintains Buy Rating - MarketScreener
BTIG maintains buy rating on Outset Medical stock after CFO change - Investing.com India
BTIG Reiterates Buy Rating on Outset Medical Inc. (OM) - StreetInsider
Outset Medical names Renee Gaeta as new CFO By Investing.com - Investing.com South Africa
Outset Medical Appoints Renee Gaeta As Chief Financial Officer - marketscreener.com
Outset Medical names Renee Gaeta as new CFO - Investing.com
Outset Medical Names Renee Gaeta as CFO - marketscreener.com
Outset Medical Appoints Renee Gaeta as CFO - TipRanks
Outset Medical Appoints Renee Gaeta as Chief Financial Officer | OM Stock News - GuruFocus
Outset Medical (OM) Welcomes Renee Gaeta as New CFO | OM Stock N - GuruFocus
Outset Medical Appoints Renee Gaeta as Chief Financial Officer - The Manila Times
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):